Stem cell-based therapies for heart failure management: a narrative review of current evidence and future perspectives

Author:

Olatunji Gbolahan,Kokori Emmanuel,Yusuf Ismaila,Ayanleke Emmanuel,Damilare Olakanmi,Afolabi Samson,Adetunji Busayo,Mohammed Saad,Akinmoju Olumide,Aboderin Gbolahan,Aderinto Nicholas

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Reference74 articles.

1. Rheault-Henry M, White I, Grover D, Atoui R (2021) Stem cell therapy for heart failure: medical breakthrough, or dead end? World J Stem Cells 13(4):236–259. https://doi.org/10.4252/wjsc.v13.i4.236

2. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Yancy CW (2022) 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145(18):e895–e1032. https://doi.org/10.1161/CIR.0000000000001063

3. Yau TM, Pagani FD, Mancini DM, Chang HL, Lala A, Woo YJ, Acker MA, Selzman CH, Soltesz EG, Kern JA, Maltais S, Charbonneau E, Pan S, Marks ME, Moquete EG, O’Sullivan KL, Taddei-Peters WC, McGowan LK, Green C, Rose EA, Network Cardiothoracic Surgical Trials (2019) Intramyocardial injection of mesenchymal precursor cells and successful temporary weaning from left ventricular assist device support in patients with advanced heart failure: a randomized clinical trial. JAMA 321(12):1176–1186. https://doi.org/10.1001/jama.2019.2341

4. Poomani MS, Mariappan I, Perumal R, Regurajan R, Muthan K, Subramanian V (2022) Mesenchymal stem cell (mscs) therapy for ischemic heart disease: a promising frontier. Glob Heart 17(1):19. https://doi.org/10.5334/gh.1098

5. Kishino Y, Fukuda K (2023) Unlocking the pragmatic potential of regenerative therapies in heart failure with next-generation treatments. Biomedicines 11(3):915. https://doi.org/10.3390/biomedicines11030915

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3